Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-04-10
1994-02-08
Fay, Zohreh A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514284, 514293, 514297, 514912, A61K 3155, A61K 3144
Patent
active
052848434
ABSTRACT:
A method of inhibiting the abnormal postnatal axial growth of the eye of a maturing animal during conditions ordinarily leading to said abnormal growth, which comprises (1) determining the neurochemical present in the retina of said eye, eg., dopamine, the concentrations of which is reduced during said conditions, and (2) administering to said eye during post natal maturation effective amounts of said neurochemical, its agonist or its antagonist.
REFERENCES:
The Merck Index tenth Edition, p. 772 (1983).
Soc Neuyosci. Abst. vol 13, part 1, p. 240, 1987.
Iuvone Paul M.
Laties Alan M.
Stone Richard A.
Emory University
Fay Zohreh A.
Trustees of the University of Penna.
LandOfFree
Pharmacological treatment of ocular development does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmacological treatment of ocular development, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmacological treatment of ocular development will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-698037